Biocon Pharma Ltd
General
Total Cases6
Active Cases1
Patents--
--
--
--
Ratings
Experience
Grade
Trend
DCT
L2
E
PTAB
L5
A
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 08/14/23 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (Attachments: # 1 Consent Judgment) (lah) (Entered: 08/14/2023) | |
| 08/14/23 | CONSENT JUDGMENT. Signed by Judge Richard G. Andrews on 8/14/2023. (lah) (Entered: 08/14/2023) | |
| 08/11/23 | PROPOSED Consent Judgment, by Merck Sharp & Dohme LLC. (Silver, Daniel) Modified on 8/11/2023 (nms). (Entered: 08/11/2023) | |
| 08/09/23 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,594,122 B2. (smg) (Entered: 08/09/2023) | |
| 08/09/23 | ORDER re 10 Notice of Voluntary Dismissal. This civil action is hereby dismissed with prejudice. The Clerk of Court shall mark this case as closed. Signed by Judge J. Nicholas Ranjan on 8/9/2023. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (pak)(smg) (Entered: 08/09/2023) | |
| 08/08/23 | NOTICE of Voluntary Dismissal by Intellectual Ventures I LLC (Farnan, Brian) (Entered: 08/08/2023) | |
| 08/07/23 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2; 10,828,310 B2. (Attachments: # 1 Order)(nms) (Entered: 08/07/2023) | |
| 08/07/23 | SO ORDERED Granting (D.I. 14 in 23-cv-334-RGA; D.I. 170 in 21-md-3017-RGA) Stipulation of Dismissal between Plaintiffs and Defendants Biocon Pharma Limited, Biocon Limited, and Biocon Pharma, Inc.. Signed by Judge Richard G. Andrews on 8/7/2023. Associated Cases: 1:21-md-03017-RGA, 1:23-cv-00334-RGA(nms) (Entered: 08/07/2023) | |
| 08/07/23 | CASE CLOSED per D.I. 15 . (nms) (Entered: 08/07/2023) | |
| 08/04/23 | STIPULATION of Dismissal between Plaintiff and Defendants Biocon Pharma Limited, Biocon Limited, and Biocon Pharma, Inc., by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 8/7/2023 (nms). (Entered: 08/04/2023) |